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Abstract: With a range of desirable mechanical and optical properties, single wall carbon 
nanotubes (SWCNTs) are a promising material for nanobiotechnologies. SWCNTs also 
have potential as biomaterials for modulation of cellular structures. Previously, we showed 
that highly purified, dispersed SWCNTs grossly alter F-actin inside cells. F-actin plays 
critical roles in the maintenance of cell structure, force transduction, transport and 
cytokinesis. Thus, quantification of SWCNT-actin interactions ranging from molecular, 
sub-cellular and cellular levels with both structure and function is critical for developing  
SWCNT-based biotechnologies. Further, this interaction can be exploited, using SWCNTs 
as a unique actin-altering material. Here, we utilized molecular dynamics simulations to 
explore the interactions of SWCNTs with actin filaments. Fluorescence lifetime imaging 
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microscopy confirmed that SWCNTs were located within ~5 nm of F-actin in cells but did 
not interact with G-actin. SWCNTs did not alter myosin II sub-cellular localization, and 
SWCNT treatment in cells led to significantly shorter actin filaments. Functionally, cells 
with internalized SWCNTs had greatly reduced cell traction force. Combined, these results 
demonstrate direct, specific SWCNT alteration of F-actin structures which can be exploited 
for SWCNT-based biotechnologies and utilized as a new method to probe fundamental 
actin-related cellular processes and biophysics. 
Keywords: actin; cytoskeleton; carbon nanotube; myosin; FLIM; cell mechanics 
 
1. Introduction 
Single wall carbon nanotubes (SWCNTs) are composed of sp2 bonded carbon atoms that are 
arranged into a quasi one-dimensional cylindrical geometry, with typical diameters ranging from  
0.7–2 nm and typical lengths ranging from 20 nm–20 cm [1,2]. SWCNTs’ unique structure leads to 
numerous desirable properties, including high mechanical strength [3], surface area-to-volume ratio [2] 
and electrical conductivity [4,5], low mass density [2], resistance to chemical degradation [1,2] and 
unique optical properties [2,6]. These properties are suited for biomedical applications, and SWCNTs 
show promise as intracellular biomaterials since they are unreactive and resistant to acids, bases, 
enzymes, mechanical fatigue and temperature. Currently, SWCNT-based biomedical applications 
include use as biosensors [7], interfaces for microelectronic devices [8], tissue imaging agents [9–11], 
actuation materials [12], delivery vehicles for nucleic acids [13–16] and drugs [10,14,17–22], 
photothermal therapy agents [23], materials to pattern tissue culture substrates and control cell 
growth [24,25] and enhancers for tissue engineering matrices [26]. We suggest that SWCNT interactions 
with intracellular components may allow for the advancement of cellular medical technologies. 
Bare SWCNTs are hydrophobic and readily flocculate due to van der Waals forces [27], and a 
“dispersing agent” is needed to stabilize individual SWCNTs in aqueous solutions. There are 
numerous dispersing agents capable of generating biocompatible SWCNTs for delivery applications. 
We have shown that SWCNTs dispersed with a biocompatible and FDA-approved triblock  
co-polymer, Pluronic F127 (PF127) [28], (SWCNTs-PF127) enter cells via endocytosis [29] and cause 
changes to filamentous actin (F-actin) structures inside the cell [30]. F-actin plays an important part in 
cellular motility, division, force generation and structure, as well as having many other indirect roles 
within the cell [31]. Modulation of the actin cytoskeleton and intracellular force generation within the 
cell also alters cell phenotype and cell differentiation [32–37]. 
SWCNTs represent a new, synthetic actin modifier, which causes in situ bundling and redistribution 
of F-actin. We have previously shown that high levels of SWCNT-PF127 treatment are associated with 
giant cells, multi-nucleated cells and cells frozen in cytokinesis [30]; therefore, high concentrations of 
SWCNTs could be used to generate populations of cells with F-actin-related defects. In this work, we 
investigated SWCNTs/actin interaction at the molecular, sub-cellular, cellular and functional levels. 
We demonstrated via molecular dynamics simulation that SWCNTs bind F-actin, and we showed the 
molecular details and strengths of binding partnership between the two. Furthermore, we investigated 
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the interactions between actin monomers in association with SWCNTs. We probed SWCNT-actin 
interactions inside cells using fluorescence lifetime imaging microscopy (FLIM), further suggesting 
that SWCNTs are preferentially associated with F-actin structures. The altered organization of  
intra-cellular F-actin structures showed a reduction in filament length and an increase in apical 
protrusions. However, there was no effect on myosin II in the presence of SWCNTs-PF127. 
Functionally, incubation of fibroblasts with SWCNTs-PF127 resulted in an isotropic reduction in 
cellular generation of traction force. Therefore, we confirmed direct SWCNT interaction with F-actin, 
and we suggest the utility of SWCNTs as a new actin modifier and potential actuator. 
2. Results and Discussion 
2.1. SWCNTs Alter F-Actin Structure  
We have shown that SWCNTs-PF127 enter cells via endocytosis, and we suggest that the 
membrane active PF127 disrupts the endosome, allowing SWCNT association with subcellular 
structures [29,30]. Many independent groups have shown that F-actin and focal adhesion structures are 
altered in cells treated with carbon nanotubes [38–44]. However, systematic investigations of 
SWCNTs with actin using complementary in vitro and in situ methods have allowed us to examine 
actin reorganization in cells and subsequent altered cellular phenotype.  
2.1.1. Actin Filament Redistribution in Human Cells 
Previously, we have visualized F-actin structures in SWCNTs-PF127-treated HeLa cells using 
confocal fluorescence microscopy [30]. In individual cells, actin filaments labeled with rhodamine 
phalloidin were mislocalized throughout the cell: (1) actin filaments throughout the height of the cell; 
(2) short peri-nuclear actin filaments; (3) “fuzzy” actin filaments at the apical surface of the cell, which 
are likely similar to; (4) actin protrusions extending radially from the edge of the cells. In addition to 
these localized changes in F-actin, we also observed global reordering of F-actin structure and a loss of 
cellular anisotropy. These changes, and the actin changes described below, were associated with 
exceptionally high levels of SWCNT treatment (>30 μg/mL); these concentrations are 1–2 orders of 
magnitude higher than treatment levels for SWCNT-based delivery systems. 
Here, we have applied a sophisticated image analysis algorithm to quantify F-actin differences 
within the cell from standard 2-dimensional images. This study examines completely isolated HeLa 
cells treated with extremely high levels of SWCNTs (100 μg/mL SWCNTs-PF127 for 24 hr) to push 
the limit of cell response and remove confounding effects from cell-cell interactions. From compressed 
confocal images of rhodamine-phalloidin-labeled F-actin of HeLa cells (Figure 1a,d), we first 
compared the raw images against a bank of artificial linear and curvilinear elements. This step 
enhanced the filaments and suppressed the background noise and fluorescence contributed by  
un-polymerized actin, subsequently generating a filament enhanced image (Figure 1b,e). From there, 
we applied binary clustering followed by a morphological thinning step on the filament enhanced 
images to determine the centerlines of actin structures (Figure 1c,f). After disambiguating centerline 
bifurcations and intersections and measuring the centerline lengths of the resultant network, we 
observed a statistically significant reduction in filament length from many samples: 4.40 +/− 0.49 μm 
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for control to 1.66 +/− 0.41 μm for SWCNT treated (p < 0.01, Figure 1g). Also, the multimodal length 
features of typical actin filaments are lost in the presence of SWCNTs. 
Figure 1. Morphometric image analysis of F-actin treated with 100 μg/mL SWCNTs-PF127: 
(a) Rhodamine phalloidin stained F-actin in control cell; (b) Filament enhanced image 
from (a) emphasizing filaments and suppressing background fluorescence; (c) Centerline of 
filaments obtained from (b); (d), (e) and (f) Corresponding images of (a), (b) and (c) with 
the entire process applied to a cell treated with SWCNTs-PF127; (g) Frequency 
distribution of actin filament length as determined from the filament centerline images  
(n = 4 control cells, n = 2 SWCNT-treated cells). Weighted average lengths are  
4.40 +/− 0.49 μm for control and 1.66 +/− 0.41 μm for SWCNT-treated (p < 0.01). 
 
Recently, we reported that human mesenchymal stem cells (hMSCs) exhibited a 5–10× increased 
SWCNT uptake compared with other cell types, including NIH-3T3 cells and HeLa cells, from the 
initial study [45], possibly due to increased metabolic activity [46,47]. Treatment of hMSCs with  
30 μg/mL SWCNTs-PF127 also showed redistribution of F-actin (Figure 2). SWCNTs-PF127-treated 
hMSCs were associated with misaligned actin filaments after only 3 hr of high levels of exposure 
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(Figure 2a). After 24 hr, regions of misaligned, isotropic F-actin were extended vertically in dramatic 
fashion (Figure 2b,c (zoomed)).  
Figure 2. Confocal images of rhodamine phalloidin-labeled F-actin of hMSCs exposed to 
SWCNTs at 30 μg/mL; (a) Confocal compressions in Z show regions of altered F-actin 
structures after only 3 hr of SWCNT exposure; (b) Confocal compressions in Y reveal that 
after 3 hr of exposure, the areas of F-actin mislocalization did not substantially extend in 
the Z-direction; however, after 24 hr of exposure, the projections in Z were overt and 
substantial; (c) Zoomed in view of (b). 
 
HeLa cells with neighboring cells treated with 30 μg/mL SWCNTs-PF127 showed cellular 
redistribution of F-actin that was less dramatic than high levels of treatment on isolated cells (Figure 3 
compared with Figure 1). Generally, we have found that isolated cells (or cells at lower seeding 
density) were more sensitive to SWCNT treatment and showed a more dramatic response [30]. Here, 
confocal imaging of F-actin structures inside cells showed redistribution from the basal region of the 
cell to spiky apical plaques, changing cell distribution, global structures and localized structures. From 
the X-Y view (Figure 3a), small F-actin projections are observed at the periphery of the cell. However, 
there was no alteration to G-actin, suggesting a specific interaction between SWCNTs and F-actin. 
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Figure 3. Confocal images of rhodamine phalloidin-labeled F-actin, Alexa Fluor 488 
DNase I-labeled G-actin and DAPI-labeled nuclei (weak blue color) of control and 
SWCNTs-PF127-treated HeLa cells: (a) Confocal compressions in Z; (b) Confocal 
compressions in Y. Scale bars are 10 μm. 
 
2.1.2. FLIM Shows F-actin-SWCNT Interactions in Vitro and in Situ 
To examine more direct interactions of SWCNTs-PF127 with actin, we used fluorescence lifetime 
imaging microscopy (FLIM) to visualize potential fluorescence lifetime quenching in the presence of 
SWCNTs (Figure 4). FLIM measures changes in the fluorescence emission decay time and is highly 
sensitive to environmental factors within the Föster radius (~5 nm) of the fluorophore, including 
electronic interactions with SWCNTs [48]. Fluorescence lifetime, dependent on fluorophore and 
chemistry within the Föster radius, can be modeled as a single or double exponential decay [48]. 
We performed FLIM of rhodamine phalloidin labeled F-actin structures inside SWCNTs-PF127-treated 
HeLa cells. SWCNTs quenched the mean fluorescence lifetime (τm) of the rhodamine, suggesting a 
close interaction (Figure 4a,b). To ensure that the quenching effects were due to SWCNT interaction 
with F-actin versus a SWCNT interaction with the fluorophore, we performed FLIM with Oregon 
Green phalloidin labeled actin filaments (Figure 4a,b). In both cases, quenching of τm was localized 
within specific F-actin regions (Figure 4a). Also, both cases showed a quantitative change in 
fluorescence lifetime profile (based on a goodness of fit, χ2, closest to unity), shifting from a single 
exponential decay for control to a double exponential decay for SWCNT-treated samples (Figure 4b). 
Interestingly, we observed no change in τm for Alexa Fluor 488 DNAse I (Figure 4a,b), which labels 
the monomeric G-actin in cells. Spatially, some fluctuations were observed in a very small range  
(~500 ps), but on average there was no change in the τm (Figure 4b).  
These studies suggest that SWCNTs show specific association with F-actin inside cells. To confirm 
SWCNT-actin filament specificity, we polymerized purified actin in vitro and treated purified actin 
filaments with bovine serum albumin (BSA), higher salt (with phosphate buffered saline, PBS), the 
SWCNT-dispersion polymer PF127 and PF127-dispersed SWCNTs (Figure 4c). The fluorescence 
lifetime of rhodamine phalloidin-labeled F-actin was only altered for SWCNT-PF127 (Figure 4c). 
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Collectively, these results suggest a preferential interaction of SWCNTs with F-actin, both inside the 
cell and in vitro.  
Figure 4. FLIM lifetime images and quantification of averaged mean fluorescence 
lifetimes (τm); (a) τm pseudo-color images of HeLa cells labeled with rhodamine phalloidin 
(left), Oregon Green phalloidin (middle) and Alexa Fluor 488 DNase I. (Note: τm = τ1 for a 
single exponential decay); (b) Quantification of (a), showing the individual lifetime time 
constants, τ1 and τ2. The exponential model (single or double) was determined by the 
model having the goodness of fit (χ2) closest to unity; (c) Quantification of fluorescence 
lifetime images from in vitro samples, as in (b). Note: the value of n reflects the number of 
images averaged, each of which consists of 256 × 256 pixels, each of which has a value of 
fluorescence lifetime (if signals were present). 
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2.1.3. Molecular Interactions with Filamentous Actin 
Although there is no unique actin-SWCNT binding site, as there is for specific protein-protein 
binding interfaces, we examined the interfacial energy to determine pseudostable binding regions. We 
simulated model F-actin filaments interacting with SWCNTs to determine possible mechanisms of 
interactions. We also considered specific interactions of F-actin using molecular dynamics simulations 
of three actin monomers combined in a filamentous arrangement (Supplementary Information, Figure 1) 
as a model segment of F-actin (Figure 5). To explore potential binding areas on the exposed surface of 
F-actin, we designed and performed six simulations, each having one SWCNT aligned parallel to the 
actin subunit (two actin monomers) but at different locations with respect to others (Figure 5a–f). 
Initial configuration of all simulations started from SWCNT-actin distances within 3–5 angstroms, 
and we observed that the potential energy of the bound structure was optimized with a stable contact 
surface area. During all simulations, SWCNTs slid constantly on the surface of actin structures along 
the length of the filament, showing that the dynamic nature of SWCNT was maintained even in the 
bound state (for further details, please see Shams et al. [49]). 
In all six simulations, the surface residues of actin formed strong interactions with the SWCNT. 
There were no electrostatic interactions between protein residues and SWCNTs since graphene bonds 
are neutral. Therefore, hydrophobic and π-π interactions were most significant in stabilizing the 
SWCNT on the surface of F-actin. Although the hydrophobic residues were mainly buried inside the 
core of actin monomers, there were a few on the surface, which were important for SWCNT binding 
such as ILE4, VAL95, PRO111, PRO331 etc. Aromatic residues, such as TYR and PHE  
(Supplementary Information, Figure 2a), formed π-π interactions with hexagonal carbon rings, and the 
elongated, planar groups on ARG (Supplementary Information, Figure 2b), ASP and LYS aligned with 
the regular surface of the SWCNT. We report the energies of interaction and percent of interacting 
residues in Table 1. 
The lowest energy SWCNT-actin complex (Figure 5a) showed SWCNT interactions with two actin 
monomers with an orientation of the SWCNT close to the actin groove. However, this interaction did 
not represent the lowest potential energy of the system since the presence of the SWCNT slightly alters 
the conformation of actin subunits within the filament. Therefore, the simulation with the lowest 
potential energy (Figure 5f) had a minimum alteration of actin subunits within the filament. Thus, there 
appears to be a dynamic instability between the optimum conformation of the actin filament and the 
optimum interaction between SWCNTs and the actin filament. Since the surface chemistry of the 
SWCNT is mostly uniform, the SWCNT is able to translocate in one dimension along the three 
monomer filament. 
We suggest that a small, non-specific interaction of the SWCNT with the available face of the actin 
monomers may be insufficient for stable association. However, a sliding behavior of SWCNTs along 
the filament may allow a continuous association of SWCNTs along F-actin (see Shams et al. for details [49]). 
This interaction may be due, in part, to similar anisotropic properties (e.g., Lc/D >> 1) of SWCNTs and 
F-actin (Table 2). Specifically, the persistence lengths of F-actin and SWCNTs are nearly similar, 
suggesting similar length scales of entropic fluctuations. 
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Figure 5. Molecular dynamics simulations of SWCNT interactions with a three actin 
monomer representation of F-actin: (a–f) represent different starting orientations between 
the actin and SWCNT, leading to different binding positions, the energies of which are 
indicated in (g); Red represents the interaction sites in all figures; (a) corresponds to the 
simulation with the lowest interaction energy, i.e., the largest number of interactions while 
(f) has the lowest potential energy since the strong association of actin monomers was less 
disturbed compared to other simulations. 
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Table 1. The energies of interaction and percent of interacting residues from the molecular 
dynamics simulations of SWCNT/actin interaction. 
Charged Polar Hydrophobic 
Amino acid Asp Arg Glu Lys His Ser Asn Gln Thr Tyr Ile Gly Pro Ala Phe Val
Energy  
(−kJ/mol) 26.4 31.4 19.7 18.7 19.0 29.6 25.2 28.1 27.1 47.0 37.4 10.4 20.7 14.0 32.7 18.8
% interacting 
residues 
19 13 8 6 4 6 2 2 2 2 12 8 8 4 4 2 
Table 2. Selected mechanical properties of SWCNTs and F-actin. 
 F-actin SWCNTs 
Lp (μm) 17 22 
D (nm) 6 0.7–1.3 
Lc (μm) ~(10) 0.150 
E (GPa) 1 1,000 
2.1.4. SWCNT-Actin Interactions 
Through the SWCNT-induced change in fluorescence lifetime, we have shown direct interactions 
(within 5 nm) of SWCNTs and purified actin filaments produced ex vivo, and intracellular FLIM 
results have suggested that SWCNTs and F-actin directly interact within cells. We suggest that the 
similarity in diameters and persistence lengths of F-actin and SWCNTs is responsible for the 
preferential interaction. Cells have a large concentration of F-actin, and we have observed delivery of 
up to 106 SWCNTs per cell [45]. These high concentration constituents associate via weak  
protein-SWCNT interactions, and the global strength of the interaction, is additive along the SWCNT 
interface with the repetitive actin filament. The anisotropic SWCNT is able to travel in one dimension 
along F-actin and maintain regions of semi-stable interaction. This dynamic association can then 
stabilize relatively short actin filaments (Figure 1) within the cell away from basal stress fibers and in 
apical F-actin structures (Figure 3). Also, SWCNT-F-actin interactions stabilize inter-actin bundling 
via lateral interactions, leading to the observed cellular phenotypes. The SWCNT-F-actin interaction 
does not appear to impact F-actin-myosin II interactions; there are no localization changes of myosin II 
except in combination with highly distorted F-actin structures. 
2.2. SWCNTs Alter F-Actin Function  
To examine what downstream effects SWCNTs have on cells by altering actin, we considered  
actin-mediated cellular functions. Previously, we have shown altered cell division in cells treated with 
high levels of SWCNTs-PF127 [30]. Specifically, we observed arrested cytokinesis at the last stage of 
mitosis, wherein reorganization of the actin cytoskeleton is required for the formation and final 
disassembly of the cytokinesis cleavage furrow.  
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2.2.1. Myosin II Partially Redistributes with Altered F-Actin Structures 
Since actin filaments are altered and redistributed inside SWCNT-treated cells, we examined 
myosin II localization in SWCNT-treated cells. We observed a minority of myosin II mislocalized 
throughout the cell, but myosin II mislocalization appeared to occur colocalized to altered F-actin 
structures (Figure 6). Specifically, we examined myosin II and F-actin mislocalization within  
peri-cellular radial protrusions (Figure 6b). We measured F-actin and myosin II in peri-cellular 
projections from the central cell body, which are common in isolated cells treated with SWCNTs. Most 
F-actin projections did not have myosin II contained within them. In the minority of projections that 
contained myosin, the myosin extended only 36 +/− 6 % of the length of the F-actin. F-actin was able 
to extend into long projections (in some cases > 10 μm), extending apically from the surface and 
radially from the cell, but myosin II is not recruited to these regions. Together, these results suggest 
that F-actin is reorganized in the presence of SWCNTs, and a small amount of myosin II is reordered 
along with the F-actin. 
2.2.2. SWCNT Treatment Alters Cell Force Generation 
With reorganized actin filaments and associated myosin II, we considered altered cellular force 
generation from redistributed actomyosin machinery. We patterned adhesive regions (40 μm × 40 μm 
squares; Figure 7) on deformable substrates with embedded tracers and allowed NIH-3T3 fibroblasts to 
attach and produce traction on the substrate. We were able to visualize the force generated by the cell 
by imaging deformation of the substrate before and after rapid cellular detachment. Our previous 
studies examined force generation capabilities with comparisons between individual cells or averaged 
mechanics [30]. However, the regular geometry of cells allowed for composite overlays of many 
SWCNTs-PF127-treated and control cells. We found that SWCNT treatment of fibroblasts reduces 
average traction force of the cells by half (Figure 7). We suggest that this reduction in traction force is 
due to loss of larger actin filaments which transect the cell allowing for larger forces. 
2.2.3. Cellular Functions Altered by High Levels of SWCNT-F-actin Interactions 
In previous studies, we observed altered cellular phenotype, including shape changes, reduced 
proliferation and altered cytokinesis associated with high levels of SWCNTs-PF127 [30]. We also 
observed reduced force generation (Figure 7). However, we suggest that these changes are primarily 
associated with altered F-actin structures. Myosin II only appears mildly displaced in cells treated with 
high levels of SWCNTs-PF127. Myosin II is only displaced with actin filaments, and myosin II 
appears less altered than F-actin (Figure 6). 
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Figure 6. Imaging of myosin II in NIH-3T3 cells: (a) Widefield fluorescence images show 
that myosin II regulation is only slightly affected by incubation with SWCNTs-PF127, 
although F-actin is alerted; (b) Confocal images of a SWCNT-treated (100 μg/mL)  
NIH-3T3 cell compressed in Z (top) and Y (bottom) show F-actin outward protrusions and 
apical protrusions, respectively. These protrusions are mostly devoid of myosin II;  
(c) Control images of NIH-3T3 fibroblasts show more defined edges with actin and myosin 
primarily at the basal region of the cell. 
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Figure 7. Fibroblast force generation; (a) Phase-contrast images of control and  
SWCNT-treated (200 μg/mL for 24 hr) NIH-3T3 cells confirmed that the cells were  
well-adhered and spread to fill the micropatterned gelatin square surface on the 
polyacrylamide hydrogel; (b) Heat map of traction force averaged over n = 16 for treated 
cells and n = 20 for control cells demonstrating that SWCNTs reduce the magnitude but do 
not alter the distribution of traction force. 
 
(a)     (b) 
3. Experimental Section  
3.1. Synthesis of SWCNTs  
SWCNTs were purified, length fractionated and dispersed as previously described [30,50–52]. The 
final product was highly purified, length-selected (145 +/− 17 nm), pristine HiPCO SWCNTs, with an 
average diameter of 1 +/− 0.3 nm [30].  
3.2. Cell Culture 
3.2.1. HeLa 
HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM), low glucose (Hyclone 
catalog number SH30021) supplemented with 10% v./v. fetal bovine serum (Invitrogen) and 1% v./v. 
penicillin/streptomycin (Invitrogen) at 37 °C and 5% CO2. Upon culture reaching ~90% confluency, 
cells were subcultured and, for imaging experiments, seeded on sterilized #1.5 glass coverslips at  
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3.0 × 104 cells/cm2. After 24 hr, cells were exposed to SWCNTs-PF127 diluted in HeLa cell culture 
media to the indicated concentration for the indicated exposure time. 
3.2.2. NIH-3T3 
NIH-3T3 cells were grown in DMEM, high glucose (Hyclone catalog number SH30022) 
supplemented with 10% v./v. newborn calf serum (Invitrogen) and 1% v./v. penicillin/streptomycin 
(Invitrogen) at 37 °C and 5% CO2. Cultures were maintained until reaching ~75% confluency (well 
before cells would form striations) and were then subcultured. Like HeLa cells, for fluorescence 
imaging experiments, NIH-3T3s were seeded on sterilized #1.5 coverslips at 3.0 × 104 cells/cm2 and 
exposed to SWCNTs after 24 hr. 
3.2.3. hMSC 
Human mesenchymal stem cells (hMCSs) (Stem Cell Technologies) were grown in GIBCO 
MesenPRO RS Basal Medium and Growth Supplement with 2 mM of L-glutamine at 37 °C and 5% 
CO2. hMSCs were not investigated beyond passage 7, and their complete media was not used for 
longer than 15 days. When hMSCs were near confluency, they were seeded at 5,000–6,000 cells/cm2 
onto sterilized #1.5 coverslips. After ~72 hr, the hMSCs were ~50% confluent, and fresh media  
was added. 
3.2.4. Incubation with SWCNTs 
After providing cells sufficient time to adhere to the substrate and to begin proliferating (typically 
24 hr for HeLa and NIH-3T3 and 72 hr for hMSC), concentrated stock solutions of SWCNTs-PF127 
were diluted in fresh, temperature-equilibrated cell culture media to their indicated final concentration 
which was added to the cell cultures. 
3.3. Microscopy 
3.3.1. Fixation and Labeling 
To prepare samples for fixed-cell imaging, the SWCNT-laden medias were aspirated; the cells were 
washed with 1× cell culture PBS; and the cells were incubated with 3.7% formaldehyde for 15 min. 
For fluorescent imaging, the fixed cells were permeabilized with 0.2% v./v. Triton X-100 for 5min. 
Cells were washed with PBS and then exposed to 0.25 μg/mL of 4',6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) (labeling DNA), 0.165 μM of rhodamine phalloidin (labeling F-actin), Oregon 
Green phalloidin (labeling F-actin) and/or 0.3 μM DNase I (labeling G-actin) for 20 min. For myosin II 
labeling, the samples were first blocked with 0.2% BSA in PBS for 1 hr. Then, the primary Myosin II 
antibody (Nonmuscle Myosin Heavy Chain II-A Polyclonal Antibody Purified, Covance) was diluted 
1:500 in PBS/0.2% BSA and incubated for 1 hr. Subsequently, the samples were washed 3× with 
PBS/0.2% BSA solution and subjected to a secondary Alexa Fluor 555 goat anti-rabbit antibody for  
1 hr. The solutions were then aspirated, the cells washed, the coverslips mounted onto glass slides 
(Fisher) using 20 μL of mounting media (Fluoromount-G, Southern Biotech) and the edges sealed. 
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3.3.2. Widefield and Confocal Fluorescence Imaging 
Widefield fluorescence microscopy was performed using an inverted Leica DMI 6000B. Images were 
acquired using a 1.4 NA, 63×, oil immersion objective and a Leica DFC350 FX charge-coupled device 
(CCD). Confocal microscopy was performed using a Leica SP5 laser scanning confocal microscope with 
a pulsed, tunable, Ti-Sapphire Coherent Chameleon Laser and three visible lasers: Argon, HeNe 543 and 
HeNe 633. Confocal scanning was performed with a pixel resolution of 1,024 × 1,024 at an acquisition 
rate of 400 Hz using a 1.4 NA, 100×, oil immersion objective. 3D image compressions to 2D were 
performed using Leica Application Suite Advanced Fluorescence (LAS AF) software. 
3.3.3. FLIM 
Time-correlated single photon counting fluorescence lifetime imaging microscopy (FLIM) was 
performed on a Leica TCS SP5 laser scanning confocal microscope with 1.4 NA, 100×, oil immersion 
objective using a pulsed, tunable, Ti-Sapphire Coherent Chameleon Laser and a Becker & Hickl  
SPC-830 photon counting device, as described previously [29]. Briefly, 256 × 256 pixel lifetime 
images were acquired for 180 s to enable accurate determination of two exponential decays and to 
minimize the coefficient of variation [48,53–55]. Fluorescence lifetime images were generated in 
SPCImage (Becker & Hickl), using binning, if necessary, to achieve peak photon counts of ≥1,000. 
The calculated single (τ1) and double exponential (τ1 and τ2) decay lifetimes, along with their relative 
magnitudes and corresponding goodness of fits, were analyzed in MATLAB [29]. For double 
exponential decays, we report the mean fluorescence lifetime (τm), which is the weighted average of τ1 
and τ2. All reported values of lifetime are the average value of lifetime averaged across all analyzed 
images per experimental condition. 
3.3.4. Traction Force Microscopy 
Traction force microscopy was performed as described previously [36]. Briefly, fluorescent beads 
were embedded in ECM patterned polyacrylamide hydrogels of known stiffness to serve as fiducial 
markers of gel displacement. SWCNT-PF127-treated and control cells were seeded on top of the gels 
and allowed to spread overnight. Images of the beads were taken before and after the manual removal 
of the cell with a microneedle. Custom software was  used to calculate bead displacement fields, which 
were then used to calculate traction stress images with the software package LIBTRC, courtesy of 
Micah Dembo (Boston University, Boston, MA, USA; [56]). 
3.4. Filament Image Processing 
The actin filament algorithm included a sequential execution of four estimation-inference steps. In the 
first step, we estimate the likelihood of pixels belonging to actin filaments and their rough orientation by 
filtering the original image with a bank of artificial filaments that differ in rotation, scale and curvature. 
We use the best response from the filters in conjunction with the original intensity to construct a filament 
likelihood (or enhanced) image. In the second step, we apply a foreground estimation algorithm similar 
to [57] to the filament enhanced image and obtain a binary image split into filament and non-filament 
portions. In the third step, we apply a morphological image thinning procedure, such as [58], to estimate 
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filament centerline locations in the binary image. The final step disambiguates the filament bifurcation 
and intersections and measures the lengths of the individual filaments in the entire image. Numerical 
validation of actin length distribution was carried out on an image bank consisting of artificially 
generated filament networks with Gaussian distributed lengths (having pre-defined mean and standard 
deviation) and increasing filament density. Across all experiments carried out, the maximum relative 
error (error in filament count divided by the real count) for filament count in each image was within 3% 
and the maximum root mean square error in filament length was within 5 pixels (with an image size of 
128 by 128 pixels, mean filament length being 50 pixels and standard deviation being 20 pixels). A more 
complete description of the method appears in [59]. 
3.5. Molecular Dynamics Simulation 
The structure of actin was obtained from the protein data bank (PDB ID: 3LUE). A 1.1 nm long, 
armchair, (5,5)-SWCNT was generated and used in all simulations [60]. Molecular dynamics (MD) 
simulations were performed using the GROMACS software package and GROMOS96 force  
field [61,62]. The SWCNT-actin complex system was solvated in a triclinic box with TIP3P explicit 
water model. Periodic boundary conditions were imposed in all three directions. The extra charge of 
the system was neutralized by adding counter ions. The system was minimized using the steepest 
descent algorithm, and was equilibrated for 500 ps. The time step of 2 fs was used. The electrostatic 
and van der Waals interactions were modeled using the Particle Mesh Ewald method and SWITCH 
algorithm, respectively. The temperature was controlled with a Nose-Hoover thermostat at 300 K and 
the pressure was kept at 1 bar using a Berendsen barostat. The total time of each simulation was 5 ns. 
The Visual Molecular Dynamics (VMD) software was used for visualizations [63]. 
4. Conclusions  
From the molecular to sub-cellular to cellular to functional levels, we have shown that SWCNTs 
preferentially interact with and alter F-actin. This work demonstrates some of the unique, important 
SWCNT sub-cellular interactions important to SWCNT biotechnology safety and development. 
Further, it suggests that SWCNTs can be used as a new type of actin altering agent, allowing for new 
fundamental biological and biophysical studies. 
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